Skip to content
  1. Home/
  2. Latest news/
  3. Global Trial Finder: Why it just got easier to enroll in a Janssen clinical study
Global Trial Finder

Global Trial Finder: Why it just got easier to enroll in a Janssen clinical study

More than 35,000 of the world’s most dedicated scientists and innovators work for the Janssen Pharmaceutical Companies of Johnson & Johnson, helping to research and develop new ways to treat and prevent some of the world’s most complex diseases.

But there’s another key component that’s necessary when it comes to finding new therapies for conditions like Alzheimer’s disease, rheumatoid arthritis and cancer: you.

Janssen Research & Development routinely conducts clinical trials to evaluate investigational medications and treatment regimens, and that requires the participation of hundreds—sometimes even thousands—of volunteers.

But finding enough willing and qualified participants can often be a challenge.

Enter the Janssen Global Trial Finder, an easy-to-use database of clinical trials that are currently accepting new participants for a variety of diseases. People interested in enrolling in a study can search by medical condition and geographic location.

“We understand both the health-related reasons people seek to participate in clinical trials, and the motivation to help others who may face similar experiences in the future,” says Bert Hartog, Ph.D., Director and Clinical Trial Innovation Lead at Janssen. “So we wanted to offer a resource for easily accessing our clinical trials globally—a resource that can enable us to continue to advance innovative medicines to treat, prevent, intercept and cure some of the most complex diseases of our time.”

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.